This week, CBS News reported that Moderna's early data from their vaccine trials show 94.5% efficacy, with 5 vaccine recipients included in the trial's 95 confirmed cases, and reinforces last week's news from Pfizer of greater than 90% efficacy (revised a few days later to closer to 95%).